Compare C3.ai Inc (AI) vs Regeneron Pharmaceuticals Inc (REGN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
C3.ai Inc vs Regeneron Pharmaceuticals Inc — how do they compare? C3.ai Inc trades at $10.59 (market cap $1.65B), while Regeneron Pharmaceuticals Inc trades at $796.38 (market cap $82.06B). The key difference: Regeneron Pharmaceuticals Inc is far larger — about 49.7× C3.ai Inc's market cap, and Regeneron Pharmaceuticals Inc pays a 0.47% dividend while C3.ai Inc pays none. Which is the better fit depends on your goals.
| AI | REGN | |
|---|---|---|
Market Cap | $1.65B | $82.06B |
Sector | Technology | Health |
52-Week High | $19.66 | $812.27 |
52-Week Low | $7.76 | $555.51 |
Enterprise Value | $1.08B | $76.77B |
Dividend Yield | — | 0.47% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About C3.ai Inc
C3.ai Inc is an enterprise artificial intelligence company. The company provides software-as-a-service applications that enable customers to rapidly develop, deploy, and operate large-scale Enterprise AI applications across any infrastructure. It provides solutions under three divisions namely, The C3 AI Suite, is a comprehensive application development and runtime environment that is designed to allow customers to rapidly design, develop, and deploy Enterprise AI applications of any type
Read more on AI →About Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →
